Protagonist Therapeutics
PTGX
PTGX
40 hedge funds and large institutions have $103M invested in Protagonist Therapeutics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
41% less capital invested
Capital invested by funds: $175M → $103M (-$72.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
40
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.42M | |
| 2 | +$1.6M | |
| 3 | +$320K | |
| 4 |
PP
PDT Partners
New York
|
+$231K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$141K |
Top Sellers
| 1 | -$1M | |
| 2 | -$721K | |
| 3 | -$466K | |
| 4 |
Morgan Stanley
New York
|
-$165K |
| 5 |
Citigroup
New York
|
-$104K |